Polotan F, Salazar C, Morito H, Abulencia M, Pantoni R, Mercado E
Virus Evol. 2023; 9(2):vead073.
PMID: 38131006
PMC: 10735293.
DOI: 10.1093/ve/vead073.
Barik S, Mohanty K, Patil S, Tripathy S, Singh D, Hanna L
Bioinformation. 2023; 18(4):371-380.
PMID: 36909690
PMC: 9997500.
DOI: 10.6026/97320630018371.
Kumar S, Lin X, Ngo T, Shapero B, Sou C, Allen J
mBio. 2021; 12(3):e0042921.
PMID: 34156262
PMC: 8262854.
DOI: 10.1128/mBio.00429-21.
Kumar S, Ju B, Shapero B, Lin X, Ren L, Zhang L
Sci Adv. 2020; 6(38).
PMID: 32938661
PMC: 7494343.
DOI: 10.1126/sciadv.abb1328.
Kamau E, Bonneau R, Kong X
Protein Eng Des Sel. 2019; 31(12):479-487.
PMID: 31038677
PMC: 6890530.
DOI: 10.1093/protein/gzz007.
Near-Full-Length Genetic Characterization of a Novel HIV-1 Unique Recombinant with Similarities to A1, CRF01_AE, and CRFO2_AG Viruses in Yaoundé, Cameroon.
Acharya A, Fonsah J, Mbanya D, Njamnshi A, Kanmogne G
AIDS Res Hum Retroviruses. 2019; 35(8):762-768.
PMID: 30860392
PMC: 6688114.
DOI: 10.1089/AID.2019.0042.
Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide.
Kumar S, Sarkar A, Pugach P, Sanders R, Moore J, Ward A
Nat Commun. 2019; 10(1):763.
PMID: 30770829
PMC: 6377653.
DOI: 10.1038/s41467-019-08738-5.
Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions.
Wibmer C, Richardson S, Yolitz J, Cicala C, Arthos J, Moore P
Nat Commun. 2018; 9(1):4489.
PMID: 30367034
PMC: 6203816.
DOI: 10.1038/s41467-018-06794-x.
A dynamic three-step mechanism drives the HIV-1 pre-fusion reaction.
Iliopoulou M, Nolan R, Alvarez L, Watanabe Y, Coomer C, Jakobsdottir G
Nat Struct Mol Biol. 2018; 25(9):814-822.
PMID: 30150645
PMC: 7056357.
DOI: 10.1038/s41594-018-0113-x.
Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control.
Soper A, Kimura I, Nagaoka S, Konno Y, Yamamoto K, Koyanagi Y
Front Immunol. 2018; 8:1823.
PMID: 29379496
PMC: 5775519.
DOI: 10.3389/fimmu.2017.01823.
Inhibitors of Deubiquitinating Enzymes Block HIV-1 Replication and Augment the Presentation of Gag-Derived MHC-I Epitopes.
Setz C, Friedrich M, Rauch P, Fraedrich K, Matthaei A, Traxdorf M
Viruses. 2017; 9(8).
PMID: 28805676
PMC: 5580479.
DOI: 10.3390/v9080222.
Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein.
Guenaga J, Garces F, de Val N, Stanfield R, Dubrovskaya V, Higgins B
Immunity. 2017; 46(5):792-803.e3.
PMID: 28514686
PMC: 5439057.
DOI: 10.1016/j.immuni.2017.04.014.
Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replication.
Soper A, Juarez-Fernandez G, Aso H, Moriwaki M, Yamada E, Nakano Y
Exp Biol Med (Maywood). 2017; 242(8):850-858.
PMID: 28346011
PMC: 5407542.
DOI: 10.1177/1535370217697384.
Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.
Jiang X, Totrov M, Li W, Sampson J, Williams C, Lu H
J Virol. 2016; 90(24):11007-11019.
PMID: 27707920
PMC: 5126360.
DOI: 10.1128/JVI.01409-16.
Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans.
Garces F, Lee J, de Val N, Torrents de la Pena A, Kong L, Puchades C
Immunity. 2015; 43(6):1053-63.
PMID: 26682982
PMC: 4692269.
DOI: 10.1016/j.immuni.2015.11.007.
Structural analysis of a novel rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120 C4 region critical for receptor and co-receptor binding.
Pan R, Chen Y, Vaine M, Hu G, Wang S, Lu S
Emerg Microbes Infect. 2015; 4(7):e44.
PMID: 26251831
PMC: 4522616.
DOI: 10.1038/emi.2015.44.
Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin.
Iwami S, Sato K, Morita S, Inaba H, Kobayashi T, Takeuchi J
Sci Rep. 2015; 5:12256.
PMID: 26184634
PMC: 4505337.
DOI: 10.1038/srep12256.
Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL.
Kumar R, Pan R, Upadhyay C, Mayr L, Cohen S, Wang X
J Virol. 2015; 89(17):9090-102.
PMID: 26109728
PMC: 4524078.
DOI: 10.1128/JVI.01280-15.
The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel.
Pan R, Gorny M, Zolla-Pazner S, Kong X
J Virol. 2015; 89(15):8003-10.
PMID: 26018158
PMC: 4505664.
DOI: 10.1128/JVI.00754-15.
Histone deacetylase inhibitor romidepsin inhibits de novo HIV-1 infections.
Jonsson K, Tolstrup M, Vad-Nielsen J, Kjaer K, Laustsen A, Andersen M
Antimicrob Agents Chemother. 2015; 59(7):3984-94.
PMID: 25896701
PMC: 4468708.
DOI: 10.1128/AAC.00574-15.